管分流与 trabeculectomy 研究的视野结局
该研究为多中心随机临床试验的队列分析,纳入 122 眼(管分流组与 trabeculectomy 组各 61 眼),比较两种手术后视野平均偏差(MD)的变化速率。结果显示管分流组 MD 变化速率为 -0.60 dB/年,trabeculectomy 组为 -0.38 dB/年(P=0.34),两组无显著差异;糖尿病史、眼压升高和基线 MD 较差与更快视野丢失相关。
要点
- 管分流与 trabeculectomy 术后视野丢失速率均较慢,两组间无显著差异。
- 糖尿病史、较高眼压和较差基线 MD 是视野进展的危险因素。
- 按眼压<18 mmHg 就诊比例或平均眼压分层,MD 斜率无显著差异。
核心结论
- 管分流植入与 trabeculectomy 联合 MMC 术后视野丢失速率均较慢,两组间无显著差异。
- 糖尿病史、较高眼压和较差基线 MD 与更快的视野丢失相关。
研究设计与样本
- 多中心随机临床试验的队列分析,纳入 122 眼(管分流组 61 眼,trabeculectomy 组 61 眼)。
- 管分流手术为 350-mm2 Baerveldt 植入物,trabeculectomy 联合 MMC(0.4 mg/ml,4 分钟)。
- 纳入既往白内障或青光眼手术患者,基线及每年随访行视野检查。
主要发现
- 共分析 436 份可靠视野,平均每眼 3.6 份。
- 基线 MD 管分流组为 -13.07 ± 8.4 dB,trabeculectomy 组为 -13.18 ± 8.2 dB(P=0.99)。
- MD 变化速率管分流组为 -0.60 dB/年,trabeculectomy 组为 -0.38 dB/年(P=0.34)。
- MD 变化速率 95%CI 管分流组为 -0.77 至 -0.44 dB/年,trabeculectomy 组为 -0.56 至 -0.20 dB/年。
- 按眼压<18 mmHg 就诊比例或平均眼压分层,MD 斜率无显著差异。
关键数值与推荐
- 视野纳入标准:假阳性率≤20% 且假阴性率≤35%。
- 视野排除标准:视力<20/400 或视力较基线下降≥2 行 Snellen 且归因于青光眼以外病因。
临床怎么用
- 对于既往接受过白内障或青光眼手术的患者,管分流与 trabeculectomy 均可实现较慢的视野丢失。
- 糖尿病、眼压较高和基线视野损害较重的患者术后视野进展风险更高,需加强监测。
局限性
- 本研究为随机临床试验的队列分析,样本量有限(122 眼)。
- 视野检查平均每眼仅 3.6 份,随访数据密度有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe visual field (VF) outcomes in the Tube Versus Trabeculectomy (TVT) Study. DESIGN: Cohort analysis of patients in a multicenter randomized clinical trial. PARTICIPANTS: A total of 122 eyes of 122 patients, with 61 eyes in both the tube shunt and trabeculectomy groups. METHODS: The TVT Study is a multicenter randomized clinical trial comparing the safety and efficacy of tube shunt surgery (350-mm2 Baerveldt implant) and trabeculectomy with mitomycin C (MMC) (0.4 mg/ml for 4 minutes) in patients with previous cataract or glaucoma surgery. Enrolled patients underwent perimetry at baseline and annual follow-up visits. The VFs were included if the false-positive rate was ≤20% and false-negative rate was ≤35%. The VFs were excluded if visual acuity <20/400 or loss of ≥2 Snellen lines from baseline was attributed to an etiology other than glaucoma. Longitudinal linear mixed-effects models with best linear unbiased predictions (BLUPs) were applied to estimate rates of change in mean deviation (MD) for each treatment group. MAIN OUTCOME MEASURE: Rate of MD change during follow-up period. RESULTS: A total of 436 reliable VFs were analyzed, with an average of 3.6 VFs per eye. Baseline MD was -13.07 ± 8.4 decibels (dB) in the tube shunt group and -13.18 ± 8.2 dB in the trabeculectomy group (P = 0.99). The rate of change in MD was -0.60 dB/year in the tube group and -0.38 dB/year in the trabeculectomy group (P = 0.34). The 95% confidence intervals for the rates of MD change were -0.77 to -0.44 dB/year in the tube group and -0.56 to -0.20 dB/year in the trabeculectomy group. No significant difference in MD slope was seen when patients were categorized by percentage of visits with intraocular pressure (IOP) <18 mmHg or by average IOP. Univariable and multivariable risk factor analyses identified history of diabetes, elevated IOP, and worse MD as baseline factors associated with more rapid VF loss. CONCLUSIONS: Slow rates of VF loss were observed after randomized surgical treatment in the TVT Study, but no significant difference in the rate of VF loss was seen after tube shunt implantation and trabeculectomy with MMC. Patients with diabetes, higher IOP, and more severe VF loss at baseline were at higher risk for VF progression.
引用
- Swaminathan SS, Jammal AA, Kornmann HL, et al. Visual Field Outcomes in the Tube Versus Trabeculectomy Study. Ophthalmology. 2020. PMID: 32327255. doi:10.1016/j.ophtha.2020.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。